Nevro (NVRO)
(Delayed Data from NYSE)
$5.10 USD
+0.39 (8.28%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $5.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Income Statements
Fiscal Year end for Nevro Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 425 | 406 | 387 | 362 | 390 |
Cost Of Goods | 135 | 130 | 121 | 112 | 122 |
Gross Profit | 290 | 276 | 266 | 250 | 268 |
Selling & Adminstrative & Depr. & Amort Expenses | 389 | 270 | 377 | 313 | 365 |
Income After Depreciation & Amortization | -99 | 6 | -111 | -63 | -96 |
Non-Operating Income | 9 | 5 | 0 | 2 | 5 |
Interest Expense | 8 | 6 | 20 | 22 | 11 |
Pretax Income | -98 | 4 | -131 | -82 | -102 |
Income Taxes | -6 | 1 | 1 | 1 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -92 | 3 | -131 | -83 | -104 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -92 | 3 | -131 | -83 | -104 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -91 | 18 | -87 | -54 | -91 |
Depreciation & Amortization (Cash Flow) | 9 | 12 | 23 | 9 | 6 |
Income After Depreciation & Amortization | -99 | 6 | -111 | -63 | -96 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.98 | 35.53 | 34.82 | 33.68 | 30.80 |
Diluted EPS Before Non-Recurring Items | -2.46 | -2.72 | -3.20 | -2.47 | -3.37 |
Diluted Net EPS (GAAP) | -2.56 | 0.08 | -3.77 | -2.47 | -3.37 |
Fiscal Year end for Nevro Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 104.16 | 101.90 | 116.18 | 103.86 | 108.81 |
Cost Of Goods | 36.69 | 30.37 | 34.70 | 34.35 | 34.37 |
Gross Profit | 67.47 | 71.53 | 81.48 | 69.52 | 74.44 |
SG&A, R&D, and Dept/Amort Expenses | 92.59 | 107.37 | 93.27 | 95.07 | 100.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | -25.12 | -35.84 | -11.79 | -25.55 | -25.64 |
Non-Operating Income | 12.55 | 17.32 | -0.61 | 3.83 | 3.01 |
Interest Expense | 6.74 | 6.51 | 3.17 | 1.62 | 1.62 |
Pretax Income | -19.31 | -25.03 | -15.56 | -23.35 | -24.25 |
Income Taxes | 0.26 | 0.38 | -6.58 | 0.13 | 0.48 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -19.58 | -25.41 | -8.98 | -23.48 | -24.72 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -19.58 | -25.41 | -8.98 | -23.48 | -24.72 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 36.94 | 36.47 | 36.28 | 36.14 | 35.92 |
Diluted EPS Before Non-Recurring Items | -0.43 | -0.70 | -0.15 | -0.65 | -0.69 |
Diluted Net EPS (GAAP) | -0.53 | -0.70 | -0.24 | -0.65 | -0.69 |